Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
[L-carnitine in valproic acid-induced hyperammonemia]
Use a cotton ball moistened with alcohol to stop any bleeding at the injection site and to clean the area
Suitable for daily use.
Here, we report a novel two-in-one protein tag, termed CSQ-tag, utilizing a calsequestrin (CSQ) protein to enable the soluble expression and calcium-dependent purification for scFvs
MoaddelRShardellMKhadeerMLovettJKadriuBRavichandranSet al
Keytruda (pembrolizumab) Disease area(s): Oncology Manufacturer(s): Merck 2024 Sales (USD): $29.48 billion Why it sold so well: Mercks flagship cancer immunotherapy Keytruda achieved expected, remarkable success in 2024, with global sales reaching $29.48 billion an 18% increase from the previous year and accounting for 46% of the companys total revenue
US$ 29.93
US$ 20.60
US$ 28.89
US$ 27.67
